Unit for Human Reproduction, 1st Dept of OB/Gyn, Medical School, Aristotle UNiversity of Thessaloniki
Thessaloniki, 54603, Greece
NCT Number: NCT02377778
In this study the aim is to compare the effect of the type of anaesthetic drug used during oocyte retrieval on fertilization rates of oocytes retrieved after ovarian stimulation for in-vitro fertilization.
Looking for future studies?
Notify Me18 year–45 year
Female
Interventional
Phase 4
Thessaloniki, 54603, Greece
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Propofol intravenous infusion for introduction and maintance of anaesthesia at doses 3-5mg depending on the total time needed for completion of oocyte retrieval
Patients will receive thiopental in addition to fentanyl for introduction and maintanance of anaesthesia at doses 7mg. IF required patients will receive a repeat dose of 1-3mg of thiopental depending on the totla time needed to complete oocyte retrieval
Time frame: First 24h after oocyte retrieval
The number of oocytes fertilized divided by the number of oocytes in which fertilization was attempted per randomized patient
Time frame: 12h after oocyte rertieval
Time frame: 14 days after embryo transfer
Patients with positive (>20 IU/L) b-hCG test at 14 days after embryo transfer
Time frame: 40 days after embryo traansfer
Number of gestational sacs per embryos transferred per patient
Time frame: 12 hours after oocyte retrieval
Aristotle University Of Thessaloniki
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02302781
Genital Diseases, Infertility
Tilburg, North Brabant, Netherlands
View Trial DetailsNCT02912988
Genital Diseases, Infertility
Hong Kong, China
View Trial DetailsNCT05802784
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Al Mansurah, Dakahlia Governorate, Egypt
View Trial DetailsNCT01743391
Genital Diseases, Infertility
Copenhagen, Hvidovre, Denmark
View Trial Details